"Female Viagra" May Be Available In September 2015

Women may soon have available by prescription the first medication developed specifically to treat Hypoactive Sexual Desire Disorder (HSDD).  Yes, a "female Viagra" could be available as early as next month (September 2015), if the FDA grants final approval.  Currently, physicians who attempt to treat this condition have been frustrated by the lack of effective medication.

The focus of this drug (Flibanserin) will be the pre-menopausal patient who gradually or suddenly finds themselves with a lack of sexual desire.  During a recent clinical trial of 8,000 women taking Flibanserin or a Placebo, a statistically significant increase of Satisfying Sexual Events (SSE) was observed in the Flibanserin group.

Flibanserin, of course, is not without side effects and possible drug interactions.  The most significant of the side effects is drowsiness, which is exacerbated by the ingestion of alcohol.  The drug is prescribed as 1 tablet daily at bedtime to diminish this effect, which will surely appear as a warning on the labeling.

Our patients deserve effective treatments for HSDD, which to date, has unfortunately been a condition without much for us to offer.  Perhaps very soon this situation will change for the better.


Michael Goodman, MD, FACOG

Michael Goodman, MD, FACOG

Dr. Goodman graduated from Georgetown University School of Medicine and then completed his residency at Georgetown University Medical Center. He specializes in Minimally Invasive Surgery, Menopause Treatments, and Infertility Treatments. Dr. Goodman is focused on helping his patients build the best and most effective treatment plans possible. He believes that mutual agreement between doctor and patient is incredibly important to the success of a treatment plan, and he likes for his patients to have a voice in their treatment.